Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors

Shaojin You, Lian Zuo, Wei LiExperimental Cancer Therapeutic Laboratory and Histopathology Core, Atlanta Research and Educational Foundation (151F), Atlanta VA Medical Center, Decatur, GA, USAAbstract: Sex hormonal milieus during the female fertility cycle modulate the tumor vascular permeability of...

Full description

Bibliographic Details
Main Authors: Shaojin You, Lian Zuo, Wei Li
Format: Article
Language:English
Published: Dove Medical Press 2010-03-01
Series:International Journal of Nanomedicine
Online Access:http://www.dovepress.com/optimizing-the-time-of-doxil-injection-to-increase-the-drug-retention--a4135
_version_ 1818904973245677568
author Shaojin You
Lian Zuo
Wei Li
author_facet Shaojin You
Lian Zuo
Wei Li
author_sort Shaojin You
collection DOAJ
description Shaojin You, Lian Zuo, Wei LiExperimental Cancer Therapeutic Laboratory and Histopathology Core, Atlanta Research and Educational Foundation (151F), Atlanta VA Medical Center, Decatur, GA, USAAbstract: Sex hormonal milieus during the female fertility cycle modulate the tumor vascular permeability of breast cancer. It has been proposed that the liposomal formulated doxorubicin (ie, Doxil), given at the menstrual/estrous stage with the predicted highest tumor vascular permeability, allows significantly increased drug retention in the breast tumor. In the current study, syngeneic murine 4T1 mammary tumors were established on the backs of female BALB/c mice and Doxil was administered at particular mouse estrous cycle stages. The results indicated that Doxil administration during certain times in the mouse estrous cycle was crucial for drug retention in 4T1 tumor tissues. Significantly higher drug concentrations were detected in the tumor tissues when Doxil was administered during the diestrus stage, as compared to when the drug injection was given at all other estrous stages. Our study also showed that the tumor-bearing mice exhibited nearly normal rhythmicity of the estrous cycle post drug injection, indicating the feasibility of continual injection of Doxil at the same estrous cycle stage. By using 4T1 cells cultured in vitro, we showed that progesterone (P4) significantly inhibited cell proliferation and the production of six tumor-derived cytokines, eg, sTNF-RI, CXCL-16, GM-CSF, MIP-1α, MIP-1γ, and Flt3-L. Some of these factors have been shown to be vascular modulators in diverse tissues. In this report, we demonstrated that the concentration of P4 in the plasma and/or estrous cycle stage of 4T1 tumor-bearing mice can be used to select the best time for administrating the liposomal anticancer drugs.Keywords: progesterone, menstrual cycle, mouse mammary tumor, Doxil, breast cancer therapy
first_indexed 2024-12-19T21:15:56Z
format Article
id doaj.art-1e0583974b574c829650b600738fccc7
institution Directory Open Access Journal
issn 1176-9114
1178-2013
language English
last_indexed 2024-12-19T21:15:56Z
publishDate 2010-03-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-1e0583974b574c829650b600738fccc72022-12-21T20:05:21ZengDove Medical PressInternational Journal of Nanomedicine1176-91141178-20132010-03-012010default221229Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumorsShaojin YouLian ZuoWei LiShaojin You, Lian Zuo, Wei LiExperimental Cancer Therapeutic Laboratory and Histopathology Core, Atlanta Research and Educational Foundation (151F), Atlanta VA Medical Center, Decatur, GA, USAAbstract: Sex hormonal milieus during the female fertility cycle modulate the tumor vascular permeability of breast cancer. It has been proposed that the liposomal formulated doxorubicin (ie, Doxil), given at the menstrual/estrous stage with the predicted highest tumor vascular permeability, allows significantly increased drug retention in the breast tumor. In the current study, syngeneic murine 4T1 mammary tumors were established on the backs of female BALB/c mice and Doxil was administered at particular mouse estrous cycle stages. The results indicated that Doxil administration during certain times in the mouse estrous cycle was crucial for drug retention in 4T1 tumor tissues. Significantly higher drug concentrations were detected in the tumor tissues when Doxil was administered during the diestrus stage, as compared to when the drug injection was given at all other estrous stages. Our study also showed that the tumor-bearing mice exhibited nearly normal rhythmicity of the estrous cycle post drug injection, indicating the feasibility of continual injection of Doxil at the same estrous cycle stage. By using 4T1 cells cultured in vitro, we showed that progesterone (P4) significantly inhibited cell proliferation and the production of six tumor-derived cytokines, eg, sTNF-RI, CXCL-16, GM-CSF, MIP-1α, MIP-1γ, and Flt3-L. Some of these factors have been shown to be vascular modulators in diverse tissues. In this report, we demonstrated that the concentration of P4 in the plasma and/or estrous cycle stage of 4T1 tumor-bearing mice can be used to select the best time for administrating the liposomal anticancer drugs.Keywords: progesterone, menstrual cycle, mouse mammary tumor, Doxil, breast cancer therapyhttp://www.dovepress.com/optimizing-the-time-of-doxil-injection-to-increase-the-drug-retention--a4135
spellingShingle Shaojin You
Lian Zuo
Wei Li
Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
International Journal of Nanomedicine
title Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
title_full Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
title_fullStr Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
title_full_unstemmed Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
title_short Optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
title_sort optimizing the time of doxil injection to increase the drug retention in transplanted murine mammary tumors
url http://www.dovepress.com/optimizing-the-time-of-doxil-injection-to-increase-the-drug-retention--a4135
work_keys_str_mv AT shaojinyou optimizingthetimeofdoxilinjectiontoincreasethedrugretentionintransplantedmurinemammarytumors
AT lianzuo optimizingthetimeofdoxilinjectiontoincreasethedrugretentionintransplantedmurinemammarytumors
AT weili optimizingthetimeofdoxilinjectiontoincreasethedrugretentionintransplantedmurinemammarytumors